2nd Annual Enhancing Clinical Trial Processes (BALS)

Venue: Le Meridien

Location: Brussels, Belgium

Event Date/Time: Oct 17, 2006 End Date/Time: Oct 18, 2006
Report as Spam


Concern over safety and an extremely competitive pharmaceutical market has driven demand for large clinical trials but will also radically change how clinical trials are regulated and designed. So how to remain responsive to future changes in this fast moving market? And how to utilize the newest technology to enhance clinical operations?

2nd Annual enhancing CT processes conference is designed to bring together executives and operational personnel from biotechnology and pharmaceutical companies, service providers, and study sites to benchmark best practices and engage in discussions. The goal is to enable participants to share insights and experiences and to examine how to conduct clinical projects the most effective way.

Key topics:
Effective utilization of electronic tools to enhance data management and training
Strategic Benefits of Conducting Clinical Research in Emerging Markets
Enhancing patient recruitment cycle times
Phase IV: Optimizing medical marketing during life cycle management
Proved methods for trial performance assessments
Best practices in running outsourcing projects – from vendor selection to contract optimization
Web based clinical trials and patient registries

Key Speakers:
Cezary Statuch, Executive Director, Global Development Organization, Bristol-Myers Squibb
James P. Kremidas, Global Enrollment Optimization, Eli Lilly Inc.
Bernard Hart, Director Clinical Science, AstraZeneca UK
Lisbet Vandvig, Associate Director, Vendor Management, Ferring Pharmaceuticals